Navigation Links
Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
Date:6/6/2009

- Late-Breaking Data from Pivotal BLOOM Trial Presented at the American Diabetes Association's 69th Scientific Sessions Expand on Previously Announced Positive Top-Line Results -

NEW ORLEANS, June 6, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today a late-breaking poster presentation of positive results from BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management), the first of two pivotal trials evaluating the safety and efficacy of lorcaserin for weight management, at the American Diabetes Association's 69th Scientific Sessions. Lorcaserin patients achieved highly significant categorical and absolute weight loss in Year 1, and continued treatment with lorcaserin in Year 2 helped significantly more patients maintain their weight loss as compared to those on placebo. Treatment with lorcaserin also resulted in highly significant improvements as compared to placebo in multiple secondary endpoints associated with cardiovascular risk. Lorcaserin did not result in increased risk of depression and was not associated with the development of cardiac valvular insufficiency.

Previously announced BLOOM data demonstrated that lorcaserin was highly efficacious, achieving statistical significance on all three co-primary efficacy endpoints, and was very well tolerated. The BLOOM results also satisfy the efficacy requirement in the most recent US Food and Drug Administration, or FDA, draft guidance for the development of drugs for weight management.

"These data provide reason for new optimism for the millions of people who struggle with managing their weight and are in need of novel, well tolerated treatments to help improve their overall health," said Steven R. Smith, M.D., Co-Principal Investigator and Professor and Assistant Director for Clinical Research at
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
2. Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results
3. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
4. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
5. Critical Pharmaceuticals Enter Sustained Release hGH Arena
6. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
9. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
10. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
11. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... -- Royal Philips (NYSE: PHG, AEX: PHIA) ... in Imaging Equipment in the 2013 Best in KLAS ... Best in KLAS and Best in Category awards for ... Computed Tomography (CT), Ingenia 1.5T and 3.0T Magnetic Resonance ... Best in KLAS Awards: Medical Imaging & Infrastructure are ...
(Date:6/18/2013)... , June 18, 2013 Unilife Corporation ("Unilife" ... designer, developer and manufacturer of injectable drug delivery systems, ... at www.unilife.com . The new site includes additional ... to occur on a regular basis. Mr. ... "As an emerging global leader for injectable drug delivery ...
(Date:6/18/2013)... , June 18, 2013  Women are frequently the ... unfortunately they often do not give the same priority ... kept information from their doctor because they were too ... to a recent survey conducted by Allergan and endorsed ... to bringing education, funding and research to the field ...
Breaking Medicine Technology:Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2Unilife Launches New Corporate Website 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 2New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 3New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 4New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 5New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 6New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 7New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 8New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors 9
... BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced that ... of $0.50 per share to all stockholders owning shares of ... announced, the conversion rate for the Company,s 2.00% Convertible Senior ... of common stock per $1,000 principal amount, as a result ...
... 1 Today, PARI Respiratory Equipment introduced the PEP S, ... used with all PARI LC reusable nebulizers. PARI,s PEP ... therapies for airway clearance and lung strengthening exercises by cystic ... is an incredible new device that improves patient care in ...
Cached Medicine Technology:PARI Respiratory Launches PEP S 2
(Date:6/18/2013)... Cheap Concert Tickets has released additional inventories ... gets underway in July. Soccer fans can add code ... , The popularity and hype of soccer has ... the hype of the game triggered the sports-minded citizens of ... the veins of fans from the Caribbean. The adrenalin ...
(Date:6/18/2013)... June 18, 2013 Daily Gossip Magazine has ... reviews and useful articles. , The magazine has decided ... to a new anabolic recipe every week . ... is the perfect guide for readers who are looking to ... at Daily Gossip reveals that anabolic food is almost entirely ...
(Date:6/18/2013)... 18, 2013 As obesity rates sky rocket ... for surgical equipment during childbirth comes as no shock. Forceps ... the mother when she is unable to do so herself ... associated with higher rates of complication for both the mother ... to the mother and child, forceps births add to the ...
(Date:6/18/2013)... SEATTLE, WA—A Washington state resident filed a ... he fell ill with a hepatitis A infection after ... The complaint was filed in Snohomish County Superior ... law firm that has filed 14 previous lawsuits ... Brian Brothers consumed “Townsend Farms Organic Antioxidant Blend” on ...
(Date:6/18/2013)... The Drug Delivery Partnering Terms and Agreements ... drug delivery partnering deals and agreements entered into by ... provides a detailed understanding and analysis of how and ... of deals are discovery or development stage whereby the ... license the license drug delivery technology. These deals tend ...
Breaking Medicine News(10 mins):Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 3Health News:Anabolic Cooking Book Review Exposes Dave Ruel’s Top 10 ‘Anabolicious’ Recipes for BodyBuilders 2Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4
... that is at the origin of brain tumors known as oligodendrogliomas, ... the most common type of malignant brain tumor. In a ... Cancer Cell , investigators found that the tumor originates in and ... are often referred to as "daughter" cells of stem cells. The ...
... out by the University of Granada (UGR) warns of the ... the different autonomous communities to improve recycling and waste disposal. ... law that the Spanish Ministry of the Environment and Rural ... "We carried out a comparison of the clinical waste management ...
... -- A newly published case history highlights the importance of ... report details a situation involving a stray dog found in ... in March 2010. When it was later learned that the ... animal shelter records and a public notification to identify people ...
... and generic drug manufacturers have long been at odds over regulations ... make use of valuable clinical trial data. A new ... is the first to calculate the financial and social costs of ... term of exclusive access will lead to higher drug costs in ...
... CHICAGO (January 6, 2011) According to a report published ... American College of Surgeons , surgery residents improved their knowledge ... of a Web-based curriculum. The expectation is for residents ... context and system of health care, as well as the ...
... thousands of synthetic molecules to fish for disease-specific antibodies, researchers ... a simple blood test. The same methodology might lead to ... in the January 7th issue of the journal Cell ... Alzheimer,s disease, it suggests it is a pretty general platform ...
Cached Medicine News:Health News:Researchers pinpoint origin of deadly brain tumor 2Health News:Clinical waste management needs specialized regulation 2Health News:How do data exclusivity periods affect pharmaceutical innovation? 2Health News:Web-based curriculum improves surgical residents' knowledge of health care business 2Health News:A blood test for Alzheimer's disease? 2Health News:A blood test for Alzheimer's disease? 3
... an elastic belt to help lift the weight ... Apron features "all around protection to cover you ... wearing and removing a breeze. For additional back ... - they reduce pressure on the vertebrae and ...
... Wrap Apron has always been a ... to put-on, adjust and take-off. Our ... The new Easy sures Wrap features ... fit more easily. The attached Thyroid ...
... Medtronic Electrodes are made of ... The exposed tip of the ... serves as the recording area. ... available. Each needle is pre-sterilized ...
... The Triage BNP Test is ... Blood test measuring B-type natriuretic peptide ... heart ventricles in response to ventricular ... hormonal marker of ventricular systolic and ...
Medicine Products: